Pretransplant MRD detection of fusion transcripts is strongly prognostic in <i>KMT2A-</i>rearranged acute myeloid leukemia
Sun Loo(Northern Health), Andrew H. Wei(The Royal Melbourne Hospital), Shaun Fleming(Peter MacCallum Cancer Centre), Jelena Jovanović(Centre de Recherche Jean Pierre Aubert), Adam Ivey(The Alfred Hospital), Ashish Bajel(The Royal Melbourne Hospital), Jenny O’Nions(University College London Hospitals NHS Foundation Trust), Ing Soo Tiong(The University of Melbourne), Nigel H. Russell(Guy's and St Thomas' NHS Foundation Trust), Chong Chyn Chua(The University of Melbourne), Jad Othman(The University of Sydney), Chun Yew Fong(Olivia Newton-John Cancer Wellness & Research Centre), Natasha S. Anstee(The University of Melbourne), David Ritchie(Peter MacCallum Cancer Centre), Nicola Potter(European Bioinformatics Institute), Robert Baker(University College London Hospitals NHS Foundation Trust), Richard Dillon(King's College London), H W Renshaw(University College London Hospitals NHS Foundation Trust), Hsin‐An Hou(National Taiwan University Hospital)
Cited by 13
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k